Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 EUR | -3.17% |
|
-4.55% | -87.21% |
06-24 | Marinus Pharmaceuticals, Inc.(NasdaqGM:MRNS) dropped from S&P Pharmaceuticals Select Industry Index | CI |
06-17 | Sector Update: Health Care Stocks Decline Premarket Monday | MT |
Evolution of the average Target Price on Marinus Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Marinus Pharmaceuticals, Inc.
HC Wainwright | |
Truist Securities | |
Baird | |
RBC Capital Markets | |
Ladenburg Thalmann | |
Oppenheimer | |
JMP Securities | |
SVB Securities LLC | |
Cantor Fitzgerald | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock
- Consensus Marinus Pharmaceuticals, Inc.